120 related articles for article (PubMed ID: 17511223)
1. [Questionnaires for GERD, QUEST and F scale].
Kusano M
Nihon Rinsho; 2007 May; 65(5):846-51. PubMed ID: 17511223
[TBL] [Abstract][Full Text] [Related]
2. Comparison of endoscopic findings with symptom assessment systems (FSSG and QUEST) for gastroesophageal reflux disease in Japanese centres.
Danjo A; Yamaguchi K; Fujimoto K; Saitoh T; Inamori M; Ando T; Shimatani T; Adachi K; Kinjo F; Kuribayashi S; Mitsufuji S; Fujiwara Y; Koyama S; Akiyama J; Takagi A; Manabe N; Miwa H; Shimoyama Y; Kusano M
J Gastroenterol Hepatol; 2009 Apr; 24(4):633-8. PubMed ID: 19220681
[TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of FSSG: frequency scale for the symptoms of GERD.
Kusano M; Shimoyama Y; Sugimoto S; Kawamura O; Maeda M; Minashi K; Kuribayashi S; Higuchi T; Zai H; Ino K; Horikoshi T; Sugiyama T; Toki M; Ohwada T; Mori M
J Gastroenterol; 2004 Sep; 39(9):888-91. PubMed ID: 15565409
[TBL] [Abstract][Full Text] [Related]
4. [Significance of PPI-test in the diagnosis of GERD].
Takahashi M; Nishiki R; Ichimura H; Takada H; Kuwayama H
Nihon Rinsho; 2004 Aug; 62(8):1465-74. PubMed ID: 15344536
[TBL] [Abstract][Full Text] [Related]
5. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease.
Gerson LB; Robbins AS; Garber A; Hornberger J; Triadafilopoulos G
Am J Gastroenterol; 2000 Feb; 95(2):395-407. PubMed ID: 10685741
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic options in the treatment of nighttime gastroesophageal reflux.
Orr WC
Digestion; 2005; 72(4):229-38. PubMed ID: 16319458
[TBL] [Abstract][Full Text] [Related]
7. The use of frequency scale for the symptoms of GERD in assessment of gastro-oesophageal reflex symptoms in asthma.
Takenaka R; Matsuno O; Kitajima K; Ono E; Hiroshige S; Nishitake T; Miyazaki E; Kumamoto T
Allergol Immunopathol (Madr); 2010; 38(1):20-4. PubMed ID: 20092933
[TBL] [Abstract][Full Text] [Related]
8. Look--but also listen! ReQuest: an essay on a new validated scale to assess the outcome of GERD treatment.
Bardhan KD; Berghöfer P
Digestion; 2007; 75 Suppl 1():87-100. PubMed ID: 17489037
[TBL] [Abstract][Full Text] [Related]
9. Prospective evaluation of the relationship between acute exacerbations of COPD and gastroesophageal reflux disease diagnosed by questionnaire.
Takada K; Matsumoto S; Kojima E; Iwata S; Okachi S; Ninomiya K; Morioka H; Tanaka K; Enomoto Y
Respir Med; 2011 Oct; 105(10):1531-6. PubMed ID: 21454063
[TBL] [Abstract][Full Text] [Related]
10. [Frequency of gastroesophageal reflux disease (GERD) as a complication in patients with chronic liver diseases: estimation of frequency scale for the system of GERD].
Ueda A; Enjoji M; Kato M; Yamashita N; Horikawa Y; Tajiri H; Kotoh K; Nakamuta M; Takayanagi R
Fukuoka Igaku Zasshi; 2007 Oct; 98(10):373-8. PubMed ID: 18046990
[TBL] [Abstract][Full Text] [Related]
11. Lower esophageal sphincter injections for the treatment of gastroesophageal reflux disease.
Watson TJ; Peters JH
Thorac Surg Clin; 2005 Aug; 15(3):405-15. PubMed ID: 16104131
[TBL] [Abstract][Full Text] [Related]
12. Sustained improvement in symptoms of GERD and antisecretory drug use: 4-year follow-up of the Stretta procedure.
Noar MD; Lotfi-Emran S
Gastrointest Endosc; 2007 Mar; 65(3):367-72. PubMed ID: 17321232
[TBL] [Abstract][Full Text] [Related]
13. Current medical management of gastroesophageal reflux disease.
Locke GR
Thorac Surg Clin; 2005 Aug; 15(3):369-75. PubMed ID: 16104127
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in the treatment of GERD in the elderly: focus on proton pump inhibitors.
Pilotto A; Franceschi M; Paris F
Int J Clin Pract; 2005 Oct; 59(10):1204-9. PubMed ID: 16178989
[TBL] [Abstract][Full Text] [Related]
15. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
[TBL] [Abstract][Full Text] [Related]
16. [GERD (gastroesophageal reflux disease)].
Dobashi K
Nihon Rinsho; 2001 Oct; 59(10):2045-50. PubMed ID: 11676152
[TBL] [Abstract][Full Text] [Related]
17. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal and intragastric pH in patients with gastroesophageal reflux disease (GERD).
Milkes D; Gerson LB; Triadafilopoulos G
Am J Gastroenterol; 2004 Jun; 99(6):991-6. PubMed ID: 15180715
[TBL] [Abstract][Full Text] [Related]
18. [GERD guideline].
Hongo M
Nihon Rinsho; 2004 Aug; 62(8):1421-6. PubMed ID: 15344529
[TBL] [Abstract][Full Text] [Related]
19. Frequency scale for symptoms of gastroesophageal reflux disease predicts the need for addition of prokinetics to proton pump inhibitor therapy.
Miyamoto M; Haruma K; Takeuchi K; Kuwabara M
J Gastroenterol Hepatol; 2008 May; 23(5):746-51. PubMed ID: 18028348
[TBL] [Abstract][Full Text] [Related]
20. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy.
Katzka DA; Paoletti V; Leite L; Castell DO
Am J Gastroenterol; 1996 Oct; 91(10):2110-3. PubMed ID: 8855731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
